R&D News | pharmaphorum

News

ASCO 25: Can GLP-1 drugs reduce cancer risk?

A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight.

News

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the disease.

News

ASCO 25: Roche places Itovebi marker in breast cancer

Roche's Itovebi has become the first PI3K inhibitor to extend survival in HR-positive, HER2-negative breast cancer with a PIK3CA mutation.

News

RFK Jr spreading 'harmful myths' on Alzheimer's research

The Alzheimer's Association has hit out at "inaccurate and dangerous fabrications" by HHS Secretary Robert F Kennedy Jr about NIH dementia research.

News

Sanofi makes Alzheimer's play with Vigil takeover

Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience.

News

US imposes limits on COVID-19 boosters and new jabs

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

ASCO 25: Can GLP-1 drugs reduce cancer risk?

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

ASCO 25: Roche places Itovebi marker in breast cancer

RFK Jr spreading 'harmful myths' on Alzheimer's research

Sanofi makes Alzheimer's play with Vigil takeover

US imposes limits on COVID-19 boosters and new jabs

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks